Bruker Corporation (BRKR) at a glance
Bruker Corporation (BRKR) is a mid-cap Healthcare company. It trades at $53.43, with a P/E of 74.9, a -0.3% profit margin and revenue growth of 2.7%. It pays a 0.4% dividend yield. Vestovix scores it 32/100 overall. Its strongest dimension is Momentum (63/100) and its weakest is Value (10/100). It carries above-market volatility, so expect larger swings.
- Price
- $53.43
- Market cap
- $8.26B
- P/E ratio
- 74.9
- Dividend yield
- 0.37%
- Beta
- 1.30
- 52-week range
- $28.53 to $65.30
Value
10
Growth
34
Income
35
Safety
38
Momentum
63
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield